Jul 28, 2026
Dr. Panicos Shangaris is from King's College London, where he is a senior clinical lecturer and consultant in maternal and fetal medicine. He discusses the treatment options for sickle cell disease, an inherited blood condition, and his work on the Pericles project, which aims to treat it before birth. In-utero gene...
Jul 28, 2026
Dr. Panicos Shangaris is from King's College London, where he is a senior clinical lecturer and consultant in maternal and fetal medicine. He discusses the treatment options for sickle cell disease, an inherited blood condition, and his work on the Pericles project, which aims to treat it before birth. In-utero gene...
Jul 8, 2026
Harith Rajagopalan, Co-Founder and CEO of Fractyl Health, is developing innovative therapies that target the root causes of obesity and metabolic diseases to achieve durable, long-lasting patient outcomes. Their drug is designed to address post-GLP-1 rebound weight gain by treating the underlying gut damage. Unlike...
Jul 8, 2026
Harith Rajagopalan, Co-Founder and CEO of Fractyl Health, is developing innovative therapies that target the root causes of obesity and metabolic diseases to achieve durable, long-lasting patient outcomes. Their drug is designed to address post-GLP-1 rebound weight gain by treating the underlying gut damage. Unlike...
Jul 6, 2026
Richard Garr, CEO and General Counsel of Curative Biotechnology, discusses the company's work in repurposing the diabetes drug metformin into an eye drop for degenerative eye diseases. The goal of the therapy is retinal preservation, aiming to slow or stop disease progression by acting at the cellular level in the back...